Comparison of two endometrial preparation methods for frozen-thawed embryo transfer in anovulatory PCOS patients: Impact on miscarriage rate.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 02 05 2021
revised: 07 04 2022
accepted: 15 04 2022
pubmed: 1 5 2022
medline: 25 5 2022
entrez: 30 4 2022
Statut: ppublish

Résumé

Some studies have suggested that patients with polycystic ovary syndrome (PCOS) are at high risk of miscarriage. However, this still remains controversial. Several potential factors might explain this association: obesity, hyperinsulinemia and hyperandrogenism. Artificial and stimulated cycles appear to be comparable for endometrial preparation in frozen-thawed embryo transfer (FET) in PCOS patients. Only a few studies have assessed miscarriage rates specifically in PCOS. We have evaluated the impact of endometrial preparation on FET outcomes in anovulatory PCOS patients. A retrospective cohort study was conducted at the Lille University Hospital, including 255 FET cycles in 134 PCOS patients between January 2011 and December 2017. PCOS was defined by the presence of at least two of the three Rotterdam's criteria. Patients were under 35 years old. Two endometrial preparation protocol were studied: stimulated cycle (gonadotropins on the second day of the cycle and luteal phase support including natural progesterone 600 mg/day) and artificial cycle (6 mg oral estradiol valerate and 800 mg micronized vaginal progesterone daily). 137 FET were performed under stimulated cycle and 118 FET under artificial cycle. Early pregnancy rates (30% versus 37.3%, p = NS), miscarriage rates (22% versus 25%, p = NS) and live birth rates (23.4% versus 26.3%, p = NS) were similar. In anovulatory PCOS women, the type of endometrial preparation does not influence FET outcomes, specifically regarding the miscarriage rate.

Identifiants

pubmed: 35489711
pii: S2468-7847(22)00079-4
doi: 10.1016/j.jogoh.2022.102399
pii:
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102399

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Auteurs

Virginie Simon (V)

Department of Reproductive Medicine, Lille University Hospital, Hospital Jeanne de Flandre, Lille F- 59000, France. Electronic address: virginie1.simon@chu-lille.fr.

Geoffroy Robin (G)

Department of Reproductive Medicine, Lille University Hospital, Hospital Jeanne de Flandre, Lille F- 59000, France; University of Lille, Lille F-59000, France.

Christine Decanter (C)

Department of Reproductive Medicine, Lille University Hospital, Hospital Jeanne de Flandre, Lille F- 59000, France.

Didier Dewailly (D)

University of Lille, Lille F-59000, France.

Sophie Catteau-Jonard (S)

Department of Reproductive Medicine, Lille University Hospital, Hospital Jeanne de Flandre, Lille F- 59000, France; University of Lille, Lille F-59000, France.

Anne-Laure Barbotin (AL)

Department of Reproductive Medicine, Lille University Hospital, Hospital Jeanne de Flandre, Lille F- 59000, France; University of Lille, Lille F-59000, France.

Pauline Plouvier (P)

Department of Reproductive Medicine, Lille University Hospital, Hospital Jeanne de Flandre, Lille F- 59000, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH